DI MISE ANNARITA

Trisciuzzi, D., Angelini, I., Gambacorta, N., Centrone, M., Ciriaco, F., Siragusa, L., et al. (2026). Early AI-driven repurposing study of existing drugs towards the vasopressin V2 receptor. COMPUTERS IN BIOLOGY AND MEDICINE, 201(15 January 2026) [10.1016/j.compbiomed.2025.111428]. Dettaglio

Angelini, I., Centrone, M., Caponio, G., Di Mise, A., Gerbino, A., Ranieri, M., et al. (2025). MOMAST® Downregulates AQP3 Expression and Function in Human Colon Cells. ANTIOXIDANTS, 14(1) [10.3390/antiox14010026]. Dettaglio

Ranieri, M., Venneri, M., Storlino, G., Ferrulli, A., D'Agostino, M., Centrone, M., et al. (2025). Alteration of vasopressin-aquaporin system in hindlimb unloading mice. FRONTIERS IN PHYSIOLOGY, 16 [10.3389/fphys.2025.1535053]. Dettaglio

Di Mise, A., Ferrulli, A., Centrone, M., Venneri, M., Ranieri, M., Tamma, G., et al. (2025). Functional Coupling of Calcium-Sensing Receptor and Polycystin-2 in Renal Epithelial Cells: Physiological Role and Potential Therapeutic Target in Polycystic Kidney Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 26(24) [10.3390/ijms262412004]. Dettaglio

Ranieri, M., Angelini, I., D'Agostino, M., Di Mise, A., Centrone, M., Venneri, M., et al. (2024). In vivo treatment with calcilytic of CaSR knock-in mice ameliorates renal phenotype reversing downregulation of the vasopressin-AQP2 pathway. THE JOURNAL OF PHYSIOLOGY, 602(13), 3207-3224 [10.1113/JP284233]. Dettaglio